David M. Euhus, MD, director of breast surgery, professor of surgery, Johns Hopkins Medicine, discusses the rarity of angiosarcoma of the breast.
David M. Euhus, MD
Advertisement
Articles by David M. Euhus, MD
David M. Euhus, MD, discusses a new trio of genes entering the risk assessment equation in hereditary breast cancer.
Advertisement
Latest Updated Articles
Dr. Euhus on the Rarity of Angiosarcoma of the BreastPublished: March 28th 2019 | Updated:
A New Trio of Genes Enters the Risk Assessment Equation in Hereditary Breast CancerPublished: March 14th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5